Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Bright Green Corporation (NASDAQ:BGXX) has disclosed its financial results for the third quarter ending September 30, 2023.
Under the leadership of executive chairman Terry Rafih, the company holds a position as one of the entities selected by the U.S. government to legally engage in the cultivation, manufacturing, and sale of cannabis and cannabis-related products for research and pharmaceutical purposes.
"Our registration by the U.S. Drug Enforcement Administration gives us the opportunity to advance our vision of improving quality of life through the opportunities presented by cannabis-derived therapies," according to the company.
Balance Sheet and Capital Allocation
As of September 30, 2023, the company maintained a cash position of $121,724.
Total liquidity, inclusive of the Lynn Stockwell credit facility, reached approximately $15.1 million.
A total of $3.1 million was raised in the first nine months of 2023 through the issuance of common stock and warrants.
Strategic Milestones
"This quarter, Bright Green was focused on several key operational and strategic milestones revolving around searching for and onboarding a new Chief Executive Officer with significant international and cannabis experience and marketing of the EB-5 capital raising program," Rafih said.
Additionally, Bright Green settled $3.6 million in debt with its largest shareholder, Lynn Stockwell, through unregistered shares and warrants.
The firm also applied for expansion, seeking regulatory approval to include additional controlled substances in compliance with state and federal laws.
"We remain committed to making strategic decisions to maximize shareholder value with minimum further dilution, as well as, capitalize on the opportunity to secure the ability to produce controlled substances beyond cannabis," Rafih concluded.
As of the latest information available, BGXX shares were observed trading down at 3.10%, reaching $0.2878 per share.
Read Next: How Bright Green Corporation Strives To Set Itself Apart In The Cannabis Industry
Posted In: BGXX